Somatic BAP1 Loss as a Predictive Biomarker of Overall Survival in Patients With Malignant Pleural Mesothelioma Treated With Chemotherapy. Ghafoor A, Hassan R. J Thorac Oncol 2022;17:862-864.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ghafoor A, Hassan R. Somatic BAP1 Loss as a Predictive Biomarker of Overall Survival in Patients With Malignant Pleural Mesothelioma Treated With Chemotherapy. J Thorac Oncol 2022;17:862-864.
PMID: 35750452